Metabolic Dysfunction–Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms

Puntos clave

• Steatotic liver disease occurs in patients following pancreatoduodenectomy, reflecting an underrecognized metabolic dysfunction.
• The analysis highlights unique pathophysiological mechanisms involved in liver disease progression post-surgery, emphasizing the need for awareness.
• Assessment of liver function and metabolic health is essential after pancreatoduodenectomy to mitigate complications.
• Developing targeted interventions may help in managing and preventing metabolic complications associated with this procedure.